Episode 74 - Roy Maute - CEO of Pheast Therapeutics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d5/e4/1e/d5e41e47-bfe8-20ea-325b-c4cfd91dca77/mza_4324065226824686757.jpg/600x600bb.jpg

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

115 episodes

2 days ago

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.

Life Sciences

Science

RSS

All content for The BioHub: The Top Voices in Biotech is the property of Max Brennan - Biotech HeadHunter and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1704904841978-1a5f9097fe03.jpg

Episode 74 - Roy Maute - CEO of Pheast Therapeutics

The BioHub: The Top Voices in Biotech

29 minutes 34 seconds

1 month ago

Episode 74 - Roy Maute - CEO of Pheast Therapeutics

On this episode we had the pleasure of featuring Roy Maute of Pheast Therapeutics.

Pheast are unleashing the power of macrophages in oncology, starting in advanced solid tumours & Ovarian Cancer. Their pipeline consists of novel innate immune checkpoint inhibitors (incl. Anti-CD24), based on research out of Irv Weissman's lab at Stanford.

In this episode we cover the inspiration behind Roy's career in oncology R&D & the origins of Pheast's name & platform, before moving onto Pheast's recent (FTD, ph1 entry) and upcoming milestones. We also cover their big ambitions for the future & how their huge focus on culture as a business has & continues to shape their journey.